Morning Movers for Feb. 26, 2014: ANIK, JAKK, ZAGG, PLUG, TASR, ANF Moving Higher, FST, UTIW, SEAC, FSLR, DWA Lower

by Paul Quintaro, Benzinga Editor
February 26, 2014 9:40 AM | 3 min read |
Moving up:
  • Anika Therapeutics ANIK - up 40% - Announces FDA Approves MONOVISC, a single injection supplement to synovial fluid of the osteoarthritic joint, used to treat pain and improve joint mobility.
  • JAKKS Pacific JAKK - up 16% - Reports Q4 EPS of $(0.73) vs $(0.82) Est; Revenue of $137.70M vs $128.88M Est.
  • Zagg Inc ZAGG - up 12.5% - Reports Q4 EPS of $(0.07) vs $0.15 Est; Revenue of $66.80M vs $61.35M Est; Sees FY2014 Sales $218.0M-228.0M vs $210.61M Est.
  • Plug Power PLUG - up 12.8% - Receives Milestone Order From Walmart for Multi-Site Hydrogen Fuel Cell Deployment.
  • TASER International TASR - up 10% - Reports Q4 EPS of $0.13 vs $0.07 Est; Revenue of $40.0M vs $37.43M Est.
  • Abercrombie & Fitch ANF - up 7.5% - Reports Q4 EPS of $1.34 vs $1.03 Est; Sees FY2014 EPS $2.15-2.35 vs $2.33 Est.
  • FuelCell Energy FCEL - up 6.5% - Moving in sympathy with Plug Power (see above). Investors betting growth in the sector as a whole will continue.
  • Rexahn Pharmaceuticals RNN - up 6.2% - Momentum from Tuesday's massive 16% continuing into Wednesday.
  • Yandex YNDX - up 5.8% - Announces Google advertising partnership for real-time bidding using DoubleClick bid manager.
  • Tesla Motors TSLA - up 4% - Nikkei reports Panasonic in talks with Tesla regarding investing $1 billion in U.S. battery factory.
  • Lowe's Companies LOW - up 3.9% - Reports Q4 EPS of $0.29 vs $0.31 Est; Revenue of $11.70B vs $11.73B Est.
Moving down:
  • Forest Oil FST - down 30% - Reports Q4 EPS of $0.02 vs $0.03 Est; Downgraded by Wells Fargo from Outperform to Market Perform.
  • UTi Worldwide UTIW - down 20% - Issues Prelim. Q4 Loss of $0.33-0.38 on Sales $1.05-1.1B.
  • QEP Resources QEP - down 15% - Reports Q4 EPS of $0.17 vs $0.41 estimates; Revenue of $715.5 million vs $767.75 million analyst estimate.
  • SeaChange International SEAC - down 15% - Reported Prelim. Q4 EPS $0.01-0.02 vs $0.19 Est., Sales $34.5-35.5M vs $43.5M Est yesterday; Brean Capital maintains Buy and lowers profit target to $14.
  • First Solar FSLR - down 13% - Reports Q4 EPS of $0.89 vs $0.99 Est; Revenue of $768.0M vs $965.38M Est; Sees Q1 EPS $0.50-0.60 vs $0.84 Est.
  • DreamWorks Animation DWA - down 11% - Reports Q4 EPS of $0.33, inline with analyst estimates. Piper Jaffray Downgrades Dreamworks Animation SKG, Inc. to Underweight, Maintains $19.00 PT.
  • Jazz Pharmaceuticals JAZZ - down 5.6% - Stifel Nicolaus Maintains Buy on Jazz Pharmaceuticals plc, Raises PT to $195.00; Cantor Fitzgerald Downgrades Jazz Pharmaceuticals plc to Hold, Raises PT to $182.00, following disappointing fourth quarter earnings.
  • Questcor Pharmaceuticals QCOR - down 4% - Reports Q4 EPS of $1.67 vs $1.66 Est; Revenue of $242.90M vs $244.15M Est.
  • Chesapeake Energy CHK - down 3% - Reports Q4 EPS of $0.27 vs $0.41 Est.
  • Halcon Resource HK - down 2.5% - RBC Capital Downgrades Halcon Resources Corporation to Sector Perform, Lowers PT to $4.00.
  • Humana HUM - down 1.9% - Citigroup Downgrades Humana Inc. to Sell.
  • Canadian Solar CSIQ - down 1.5% - Receives C$52M Non-Recourse Construction Loan from Natixis.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsMovers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!